Literature DB >> 19283960

Concomitant therapy for acne in patients with skin of color: a case-based approach.

Andrew F Alexis1, Angela Lamb.   

Abstract

Acne affects individuals of all races and ethnicities. Patients with skin of color present a unique challenge, particularly due to the potential for post-inflammatory hyperpigmentation. Concomitant therapy is an appropriate strategy for this population, as demonstrated in the following case.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283960

Source DB:  PubMed          Journal:  Dermatol Nurs        ISSN: 1060-3441


  5 in total

1.  A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne.

Authors:  Valerie D Callender; Norman Preston; Cris Osborn; Lori Johnson; Ronald W Gottschalk
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 2.  The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation.

Authors:  Nada Elbuluk; Pearl Grimes; Anna Chien; Iltefat Hamzavi; Andrew Alexis; Susan Taylor; Noelani Gonzalez; Jonathan Weiss; Seemal R Desai; Sewon Kang
Journal:  Am J Clin Dermatol       Date:  2021-09-01       Impact factor: 7.403

3.  Alteration of some cellular function in amikacin resistant Pseudomonas aeruginosa transfected macrophages: a time dependent approach.

Authors:  Subhankari Prasad Chakraborty; Santanu Karmahapatra; Sabyasachi Das; Somenath Roy
Journal:  Asian Pac J Trop Biomed       Date:  2011-12

Review 4.  An innovative approach to the topical treatment of acne.

Authors:  Adele Sparavigna; Beatrice Tenconi; Ileana De Ponti; Laura La Penna
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-09

Review 5.  The prevalence of acne in Mainland China: a systematic review and meta-analysis.

Authors:  Danhui Li; Qiang Chen; Yi Liu; Tingting Liu; Wenhui Tang; Shengjie Li
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.